OTCMKTS:SDZNY Sandoz Group (SDZNY) Stock Price, News & Analysis $44.36 -0.34 (-0.76%) As of 05/7/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsShort InterestBuy This Stock About Sandoz Group Stock (OTCMKTS:SDZNY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sandoz Group alerts:Sign Up Key Stats Today's Range$44.32▼$46.0050-Day Range$37.15▼$44.7052-Week Range$34.36▼$49.81Volume88,575 shsAverage Volume40,674 shsMarket Capitalization$19.52 billionP/E RatioN/ADividend Yield0.90%Price TargetN/AConsensus RatingHold Company OverviewSandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.Read More… Sandoz Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks62nd Percentile Overall ScoreSDZNY MarketRank™: Sandoz Group scored higher than 62% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Sandoz Group.Read more about Sandoz Group's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth22.96% Earnings GrowthEarnings for Sandoz Group are expected to grow by 22.96% in the coming year, from $2.70 to $3.32 per share.Price to Earnings Growth RatioSandoz Group has a PEG Ratio of 0.61. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioSandoz Group has a P/B Ratio of 2.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.01% of the float of Sandoz Group has been sold short.Short Interest Ratio / Days to CoverSandoz Group has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sandoz Group has recently decreased by 11.25%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldSandoz Group has a dividend yield of 0.94%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthSandoz Group does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Sandoz Group will have a dividend payout ratio of 12.05% next year. This indicates that Sandoz Group will be able to sustain or increase its dividend.Read more about Sandoz Group's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.01% of the float of Sandoz Group has been sold short.Short Interest Ratio / Days to CoverSandoz Group has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sandoz Group has recently decreased by 11.25%, indicating that investor sentiment is improving significantly. News and Social Media2.7 / 5News SentimentN/A News SentimentSandoz Group has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Sandoz Group this week, compared to 1 article on an average week.Search Interest3 people have searched for SDZNY on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Sandoz Group insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.06% of the stock of Sandoz Group is held by institutions.Read more about Sandoz Group's insider trading history. Receive SDZNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sandoz Group and its competitors with MarketBeat's FREE daily newsletter. Email Address SDZNY Stock News HeadlinesSandoz Group AG (SDZNY) Q1 2025 Earnings Call TranscriptMay 2, 2025 | seekingalpha.comSandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmedApril 30, 2025 | globenewswire.com3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. May 8, 2025 | Timothy Sykes (Ad)Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indicationsApril 29, 2025 | globenewswire.comSandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient accessApril 28, 2025 | reuters.comSandoz shareholders approve all resolutions at Annual General MeetingApril 16, 2025 | markets.businessinsider.comShareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AGApril 15, 2025 | globenewswire.com[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the USApril 14, 2025 | globenewswire.comSee More Headlines SDZNY Stock Analysis - Frequently Asked Questions How have SDZNY shares performed this year? Sandoz Group's stock was trading at $40.50 on January 1st, 2025. Since then, SDZNY stock has increased by 9.5% and is now trading at $44.36. View the best growth stocks for 2025 here. How do I buy shares of Sandoz Group? Shares of SDZNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:SDZNY CIK1992829 Webwww.sandoz.com Phone41-61-324-11-11FaxN/AEmployees22,633Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio16.43 P/E Growth0.61Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$9.65 billion Price / Sales2.02 Cash Flow$2.09 per share Price / Cash Flow21.22 Book Value$20.08 per share Price / Book2.21Miscellaneous Outstanding Shares440,000,000Free FloatN/AMarket Cap$19.52 billion OptionableNot Optionable Beta0.39 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:SDZNY) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersIt may already be too late… A global energy shift is underway—and lithium is at the center of it. From electric vehicles to grid storage a...Huge Alerts | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredYour Wealth is Being Erased – Save It Before It’s Gone ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sandoz Group AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Sandoz Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.